Tibet Cheezheng Tibetan Medicine (002287.SZ) plans to invest 90 million to 160 million yuan to repurchase shares.

Tibet Cheezheng Tibetan Medicine (002287.SZ) announced that the company plans to use its own funds to repurchase its A shares through centralized bidding trading. The repurchased shares will be used for equity incentives or employee stock ownership plans. The total amount of this repurchase is not less than RMB 90 million and not more than RMB 160 million. The repurchase price will not exceed RMB 31.65 per share. Based on the calculation of the upper and lower limits of the repurchase total amount and the repurchase share price limit, it is estimated that the number of repurchased shares will be approximately 2.8436 million to 5.0553 million shares, accounting for approximately 0.5354% to 0.9519% of the company's current total share capital.